aap Implantatereported 3Q19 revenue of €2.8 million (USD $3.1 million), -0.1% vs. 3Q18.
The company expects 2019 sales in the range of $12.4 (+1.7%) to $14.6 million (+20.1%)
The decline in the U.S. was characterized as “temporary” due to the termination of a distributor sales relationship; since late September, weekly U.S. sales are growing at double the rate of the prior year
Received approval for a human clinical study of their silver coating technology for implants and has started generating preclinical data for resorbable magnesium implant technology
aap plans to launch the polyaxial LOCTEQ foot and calcaneus system in the U.S. in 2020
ORTHOWORLD projects aap Implantate full year 2019 revenue of $12.9 million, +5.8% vs. 2018
Revenue Data
All revenue data is provided in USD millions unless otherwise noted. Sales and growth rates are estimated on an as-reported basis.
Segment Sales
3Q19
3Q18
$ Chg
% Chg
Trauma
$3.1
$3.1
($0.0)
(0.1%)
9Mo 19
9Mo 18
$ Chg
% Chg
Trauma
$9.8
$9.3
$0.5
5.6%
Geographic Sales
3Q19
3Q18
$ Chg
% Chg
US
$0.5
$0.5
($0.0)
(3.5%)
Ex-US
$2.6
$2.6
$0.0
0.6%
Total
$3.1
$3.1
($0.0)
(0.1%)
Mike Evers is ORTHOWORLD’s Digital Content Strategist. He can be reached by email.
aap Implantatereported 3Q19 revenue of €2.8 million (USD $3.1 million), -0.1% vs. 3Q18.
The company expects 2019 sales in the range of $12.4 (+1.7%) to $14.6 million (+20.1%) The decline in the U.S. was characterized as “temporary” due to the termination of a distributor sales relationship; since late September, weekly U.S. sales...
aap Implantatereported 3Q19 revenue of €2.8 million (USD $3.1 million), -0.1% vs. 3Q18.
The company expects 2019 sales in the range of $12.4 (+1.7%) to $14.6 million (+20.1%)
The decline in the U.S. was characterized as “temporary” due to the termination of a distributor sales relationship; since late September, weekly U.S. sales are growing at double the rate of the prior year
Received approval for a human clinical study of their silver coating technology for implants and has started generating preclinical data for resorbable magnesium implant technology
aap plans to launch the polyaxial LOCTEQ foot and calcaneus system in the U.S. in 2020
ORTHOWORLD projects aap Implantate full year 2019 revenue of $12.9 million, +5.8% vs. 2018
Revenue Data
All revenue data is provided in USD millions unless otherwise noted. Sales and growth rates are estimated on an as-reported basis.
Segment Sales
3Q19
3Q18
$ Chg
% Chg
Trauma
$3.1
$3.1
($0.0)
(0.1%)
9Mo 19
9Mo 18
$ Chg
% Chg
Trauma
$9.8
$9.3
$0.5
5.6%
Geographic Sales
3Q19
3Q18
$ Chg
% Chg
US
$0.5
$0.5
($0.0)
(3.5%)
Ex-US
$2.6
$2.6
$0.0
0.6%
Total
$3.1
$3.1
($0.0)
(0.1%)
Mike Evers is ORTHOWORLD’s Digital Content Strategist. He can be reached by email.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.
Copy to clipboard 
